Serum dilution neutralization test for California group virus identification and serology
about
Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile diseaseChikungunya virus in US travelers returning from India, 2006Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infectionsArbovirus-related encephalitisDetection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assayDuplex microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodiesA rhesus macaque model of Asian-lineage Zika virus infectionNew Paradigms for Virus Detection, Surveillance and Control of Zika Virus Vectors in the Settings of Southeast AsiaDetection of Anti-West Nile Virus Immunoglobulin M in Chicken Serum by an Enzyme-Linked Immunosorbent AssayLymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccineCalifornia group virus encephalitis in three children from Quebec: clinical and serologic findingsDefining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster ModelImmunoassay Targeting Nonstructural Protein 5 To Differentiate West Nile Virus Infection from Dengue and St. Louis Encephalitis Virus Infections and from Flavivirus VaccinationValidation of a Microsphere-Based Immunoassay for Detection of Anti-West Nile Virus and Anti-St. Louis Encephalitis Virus Immunoglobulin M AntibodiesTyping of LaCrosse, snowshoe hare, and Tahyna viruses by analyses of single-strand conformation polymorphisms of the small RNA segmentsDengue in the SeychellesMatrix Metalloproteinase 9 Facilitates West Nile Virus Entry into the BrainSerum antibodies to West Nile virus in naturally exposed and vaccinated horsesAre North American Bunyamwera Serogroup Viruses Etiologic Agents of Human Congential Defects of the Central Nervous System?Specificity of immunoglobulin M and G antibody responses in humans infected with eastern and western equine encephalitis viruses: application to rapid serodiagnosisIdentification of an antigenic subtype of eastern equine encephalitis virus isolated from a humanEvaluation of Chimeric Japanese Encephalitis and Dengue Viruses for Use in Diagnostic Plaque Reduction Neutralization TestsEnzyme-linked immunosorbent assay typing of California serogroup viruses isolated in CanadaImmunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitisEvaluation of the solid-phase radioimmunoassay for diagnosis of St. Louis encephalitis infection in humansIndirect fluorescent-antibody technique for serological diagnosis of La Crosse (California) virus infectionsNeutralizing antibody responses of humans and mice to vaccination with Venezuelan encephalitis (TC-83) virusDetection by enzyme-linked immunosorbent assay of antibodies to West Nile virus in birdsSerodiagnosis of La Crosse virus infections in humansProduction of hemagglutinating of La Crosse virus by polyethylene glycol precipitationDiagnosis of California La Crosse virus infection by counterimmunoelectrophoresisExperimental Passage of St. Louis Encephalitis Virus In Vivo in Mosquitoes and Chickens Reveals Evolutionarily Significant Virus CharacteristicsHigh Throughput Quantitative Colorimetric Microneutralization Assay for the Confirmation and Differentiation of West Nile Virus and St. Louis Encephalitis VirusHeterologous Protection against Asian Zika Virus Challenge in Rhesus MacaquesZoonotic infections among employees from Great Smoky Mountains and Rocky Mountain National Parks, 2008-2009Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay.West Nile virus infectious replicon particles generated using a packaging-restricted cell line is a safe reporter system.Population variation of West Nile virus confers a host-specific fitness benefit in mosquitoesAcute arboviral infections in Guinea, West Africa, 2006.Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays.
P2860
Q24273313-4EEFBEB8-377C-4DBC-8D2A-29A2FA4C707AQ24286947-B88590AF-0CC8-42DA-BF26-49E6C7A3C85CQ24570051-6AB0CCCF-C847-4C71-8789-474F98D149DEQ24650350-9B036036-00D2-4664-A42C-89C8B5BB27BDQ24727662-7E6072FA-6461-4D0F-8BBB-CB91A31DAF6BQ24727663-995B2145-AC80-455D-8D93-38B1779061B8Q25160538-9F071120-6115-4BB6-B88D-97182BE4AC2CQ27468724-9485E145-2F25-4822-A89C-5B2B85468F29Q27473493-E60B7B8D-AE5E-4C49-9768-3C912CDE08D8Q27477782-FBD9CD7F-BF95-4A9E-B34A-F5DEA6B7AB9EQ27478094-C300413F-9ACF-43C0-9EC6-D2A2FAA02C4BQ27480795-3DEABB17-9AF3-47CA-8C57-395668F9450CQ27480960-D532DB3F-9563-4D39-8657-4E6494B73C61Q27481416-E1F80D14-C515-4618-9462-A2DC28787F31Q27485676-ED852EE1-19C2-4E19-8906-964844665D74Q27486147-0F6CEE2C-9DBE-4919-A269-9FFB4950EF4BQ27486919-0E4740E9-CC0C-4831-9FE4-46EC3375CF45Q27487014-EA7FC92E-E2AB-41B7-9DC8-C8B38038681CQ27487582-4B60D385-A247-4CFF-B0FE-7815644E06DCQ27488423-7832CA33-0998-42CC-8820-7AEDFA21219DQ27488752-2EF36DDF-C9C7-47D9-86B8-579C601C93BEQ27488878-9D1515B3-533D-4913-B7B9-A76F338F8798Q27488933-935A14D6-D810-46A9-AF03-769C6CCEB1F9Q27488947-05F25BA9-7E1C-4FCC-B6BC-EAAD40D403A1Q27489044-7A266342-26A4-47C6-8F76-D17DA56B107EQ27489090-A841B88A-82F5-4CE6-921E-0D4E78E75E2FQ27489400-541AC78F-BB18-4294-A29A-671D22DEDA99Q27489411-289A23AF-094F-4287-B603-4B123CCA48C2Q27489509-998806D8-AE6F-4FDF-8183-D71BBD47C60AQ27489541-44FA8853-E61E-44BE-94A4-5179594F2E68Q27489739-A964ACD3-5A8D-41A7-9613-819859C44D61Q27490341-6D2ACAA9-EBDB-4F48-9122-9888D71D977DQ27490992-D8BBDF20-F377-4C4C-AB60-35551FB4FFA8Q27980556-77F1299D-5A14-4913-B333-E7C9B57D2445Q28392519-541227DF-C662-458A-B4F3-D860D9602B1DQ30827379-D7D97D6E-163A-4997-8D45-FD6AFCF80E53Q33789772-EC362583-2E9F-4D68-B5B9-01D4A7E5AA86Q33932147-B1D6E424-EAC5-459D-BAA0-1508ACB5FE1FQ34024894-1463FD01-6FC9-460C-A1BD-3FCAB3EBD7C0Q34240178-E694AA35-5B8E-4EEC-A65E-5E9AE96C8070
P2860
Serum dilution neutralization test for California group virus identification and serology
description
1976 nî lūn-bûn
@nan
1976 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Serum dilution neutralization test for California group virus identification and serology
@ast
Serum dilution neutralization test for California group virus identification and serology
@en
Serum dilution neutralization test for California group virus identification and serology
@nl
type
label
Serum dilution neutralization test for California group virus identification and serology
@ast
Serum dilution neutralization test for California group virus identification and serology
@en
Serum dilution neutralization test for California group virus identification and serology
@nl
prefLabel
Serum dilution neutralization test for California group virus identification and serology
@ast
Serum dilution neutralization test for California group virus identification and serology
@en
Serum dilution neutralization test for California group virus identification and serology
@nl
P2093
P2860
P3181
P1476
Serum dilution neutralization test for California group virus identification and serology
@en
P2093
C H Calisher
H S Lindsey
J H Mathews
P2860
P304
P3181
P407
P577
1976-12-01T00:00:00Z